(Q46544589)

English

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.

scientific article published on 12 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

author name string

István Gyertyán

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Katalin Sághy

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Judit Laszy

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Ottilia Elekes

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Rita Kedves

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Larisza I Gémesi

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Gabriella Pásztor

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Mária Zájer-Balázs

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Margit Kapás

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Eva Agai Csongor

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

György Domány

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Béla Kiss

12

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Zsolt Szombathelyi

13

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

publication date

12 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Naunyn-Schmiedeberg's Archives of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

378

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

529-539

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

https://scigraph.springernature.com/pub.10.1007/s00210-008-0311-x

0 references

The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0311-X

21 January 2018

Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

General pharmacology of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An overview of the mechanism of action of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D3 dopamine receptor, behavioral sensitization, and psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the amisulpride isomers on rat catalepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride: from animal pharmacology to therapeutic action

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18548231

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00210-008-0311-X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18548231

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46544589&oldid=1401398978"